James J Mule (James Mulé, James J Mulé)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 13

Top Topics

Renal Cell Carcinoma

Peripheral Blood

Top Venues

Journal for immunotherapy of cancer

Nature communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jason John Luke, Omid Hamid, Bernard A Fox, Paolo Antonio Ascierto, Iman Osman, James J Mule, Pedro J Romero, Michael T Lotze
Jeffrey S Weber, MD, PhD (1952-2024): in memoriam to discovery, friendship and family. Journal for immunotherapy of cancer 12 (9) (2024)
Nicholas H Chakiryan, Youngchul Kim, Anders E Berglund, Andrew Chang, Gregory J Kimmel, Ali Hajiran, Jonathan Nguyen, Carlos Moran Segura, Daryoush Saeed-Vafa, Esther N Katende, Neale Lopez-Blanco, Jad Chahoud, Phillip M Rappold, Philippe E Spiess, Michelle Fournier, Daniel Jeong, Liang Wang, Jamie K Teer, Jasreman Dhillon, Fengshen Kuo, Abraham Ari Hakimi, Philipp M Altrock, James J Mule, Brandon J Manley
Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma. Journal for immunotherapy of cancer 11 (4) (2023)
Rana Falahat, Anders E Berglund, Patricio Perez-Villarroel, Ryan M Putney, Imene Hamaidi, Sungjune Kim, Shari Pilon-Thomas, Glen N Barber, James J Mule
Epigenetic state determines the in vivo efficacy of STING agonist therapy. Nature communications 14 (1) (2023)
Rana Falahat, Anders E Berglund, Patricio Perez-Villarroel, Ryan M Putney, Imene Hamaidi, Sungjune Kim, Shari Pilon-Thomas, Glen N Barber, James J Mule
Epigenetic state determines the in vivo efficacy of STING agonist therapy. Nature communications 14 (1) (2023)
Rana Falahat, Anders E Berglund, Patricio Perez-Villarroel, Ryan M Putney, Imene Hamaidi, Sungjune Kim, Shari Pilon-Thomas, Glen N Barber, James J Mule
Epigenetic state determines the in vivo efficacy of STING agonist therapy. Nature communications 14 (1) (2023)
Alex C Soupir, Mitchell T Hayes, Taylor C Peak, Oscar E Ospina, Nicholas H Chakiryan, Anders E Berglund, Paul A Stewart, Jonathan V Nguyen, Carlos Moran Segura, Natasha L Francis, Paola M Ramos Echevarria, Jad Chahoud, Roger Li, Kenneth Y Tsai, Jodi A Balasi, Yamila Caraballo Peres, Jasreman Dhillon, Lindsey A Martinez, Warren E Gloria, Nathan Schurman, Sean Kim, Mark Gregory, James J Mule, Brooke L Fridley, Brandon J Manley
Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment. bioRxiv : the preprint server for biology (2023)
MacLean S Hall, Jamie K Teer, Xiaoqing Yu, Holly Branthoover, Sebastian A Snedal, Madeline Rodriguez-Valentin, Luz Nagle, Ellen Scott, Benjamin I Schachner, Patrick Innamarato, Amy M Hall, Jamie Blauvelt, Carolyn J Rich, Allison D Richards, Jake Ceccarelli, T J Langer, Sean J Yoder, Matthew S Beatty, Cheryl A Cox, Jane L Messina, Daniel Abate-Daga, James J Mule, John E Mullinax, Amod A Sarnaik, Shari Pilon-Thomas
Neoantigen-specific CD4 + tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients. Journal for immunotherapy of cancer 11 (10) (2023)
Xiaofei Song, Shiun Chang, Lucia Seminario-Vidal, Alvaro de Mingo Pulido, Leticia Tordesillas, Xingzhi Song, Rhianna A Reed, Andrea Harkins, Shannen Whiddon, Jonathan V Nguyen, Carlos Moran Segura, Chaomei Zhang, Sean Yoder, Zena Sayegh, Yun Zhao, Jane L Messina, Carly M Harro, Xiaohui Zhang, José R Conejo-Garcia, Anders E Berglund, Lubomir Sokol, Jianhua Zhang, Paulo C Rodriguez, James J Mule, Andrew P Futreal, Kenneth Y Tsai, Pei-Ling Chen
Genomic and Single-Cell Landscape Reveals Novel Drivers and Therapeutic Vulnerabilities of Transformed Cutaneous T-cell Lymphoma. Cancer discovery 12 (5) (2022)
Shota Aoyama, Ryosuke Nakagawa, Satoshi Nemoto, Patricio Perez-Villarroel, James J Mule, Adam William Mailloux
Checkpoint blockade accelerates a novel switch from an NKT-driven TNFα response toward a T cell driven IFN-γ response within the tumor microenvironment. Journal for immunotherapy of cancer 9 (6) (2022)
Meghan C Ferrall-Fairbanks, Nicholas H Chakiryan, Boris I Chobrutskiy, Youngchul Kim, Jamie K Teer, Anders E Berglund, James J Mule, Michelle Fournier, Erin M Siegel, Jasreman Dhillon, Seyed Shayan A Falasiri, Juan F Arturo, Esther N Katende, George Blanck, Brandon J Manley, Philipp M Altrock
Quantification of T- and B-cell Immune Receptor Distribution Diversity Characterizes Immune Cell Infiltration and Lymphocyte Heterogeneity in Clear Cell Renal Cell Carcinoma. Cancer research 82 (5) (2022)
Caitlin A Creasy, Yuzhong Jeff Meng, Marie-Andrée Forget, Tatiana Karpinets, Katarzyna Tomczak, Chip Stewart, Carlos A Torres-Cabala, Shari A Pilon-Thomas, Amod A Sarnaik, James J Mule, Levi Garraway, Matias A Bustos, Jianhua Zhang, Sapna Pradyuman Patel, Adi Diab, Isabella C Glitza Oliva, Cassian Yee, Hussein Tawbi, Michael K Wong, Jennifer Leigh McQuade, Dave S B Hoon, Michael A Davies, Patrick Hwu, Rodabe N Amaria, Cara L Haymaker, Rameen Beroukhim, Chantale Bernatchez
Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (9) (2022)
MacLean S Hall, John E Mullinax, Cheryl A Cox, Amy M Hall, Matthew S Beatty, Jamie Blauvelt, Patrick Innamarato, Luz E Nagle, Holly Branthoover, Doris Wiener, Benjamin I Schachner, Alberto J Martinez, Allison D Richards, Carolyn J Rich, Marjorie Colón Colón, Michael J Schell, Jamie K Teer, Nikhil I Khushalani, Jeffrey S Weber, James J Mule, Vernon K Sondak, Shari A Pilon-Thomas, Amod A Sarnaik
Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Rana Falahat, Patricio Perez-Villarroel, Adam W Mailloux, Genyuan Zhu, Shari Pilon-Thomas, Glen N Barber, James J Mule
STING Signaling in Melanoma Cells Shapes Antigenicity and Can Promote Antitumor T-cell Activity. Cancer immunology research 7 (11) (2019)